Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating safety, tolerability, and efficacy of OTX-CSI for dry eye disease has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OTX-CSI

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-14